Phosphorylation state and protein levels measured in BRAF(V600E/D) melanoma cell lines monitored by imaging - Dataset (ID:20219)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | 2nd Drug | Drug Concentration | Conc Unit | Time Point | Time Point Unit | Image | Measured Protein (Alexa Fluor 488) | Measured Protein Value (488) | Measured Protein (Alexa Fluor 568) | Measured Protein Value (568) | Measured Protein (Alexa Fluor 647) | Measured Protein Value (647) | Replicate | Plate Name | Plate Well |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0000 | uM | 24 | hr | p27 Kip1 | 447.88 | p-Rb(S807/S811) | 161.30 | p-ERK(T202/Y204) | 568.39 | 2 | Colo858-signal1 | G11 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 5.0000 | uM | 24 | hr | p27 Kip1 | 1526.80 | p-Rb(S807/S811) | 101.09 | p-ERK(T202/Y204) | 29.24 | 2 | Colo858-signal1 | G2 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 2.0000 | uM | 24 | hr | p27 Kip1 | 1676.60 | p-Rb(S807/S811) | 60.57 | p-ERK(T202/Y204) | 20.44 | 2 | Colo858-signal1 | G3 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.8000 | uM | 24 | hr | p27 Kip1 | 1044.90 | p-Rb(S807/S811) | 48.21 | p-ERK(T202/Y204) | 22.38 | 2 | Colo858-signal1 | G4 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.3200 | uM | 24 | hr | p27 Kip1 | 983.23 | p-Rb(S807/S811) | 56.72 | p-ERK(T202/Y204) | 28.24 | 2 | Colo858-signal1 | G5 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.1280 | uM | 24 | hr | p27 Kip1 | 743.36 | p-Rb(S807/S811) | 68.92 | p-ERK(T202/Y204) | 51.05 | 2 | Colo858-signal1 | G6 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0512 | uM | 24 | hr | p27 Kip1 | 511.00 | p-Rb(S807/S811) | 125.23 | p-ERK(T202/Y204) | 254.95 | 2 | Colo858-signal1 | G7 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0205 | uM | 24 | hr | p27 Kip1 | 458.83 | p-Rb(S807/S811) | 152.02 | p-ERK(T202/Y204) | 459.90 | 2 | Colo858-signal1 | G8 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0082 | uM | 24 | hr | p27 Kip1 | 456.27 | p-Rb(S807/S811) | 159.28 | p-ERK(T202/Y204) | 556.01 | 2 | Colo858-signal1 | G9 | |
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.3200 | uM | 24 | hr | p27 Kip1 | 441.68 | p-Rb(S807/S811) | 125.56 | p-ERK(T202/Y204) | 43.30 | 1 | LOXIMVI-signal1 | F5 | |
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.0512 | uM | 24 | hr | p27 Kip1 | 338.89 | p-Rb(S807/S811) | 176.50 | p-ERK(T202/Y204) | 86.35 | 1 | LOXIMVI-signal1 | F7 | |
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.0205 | uM | 24 | hr | p27 Kip1 | 304.49 | p-Rb(S807/S811) | 193.11 | p-ERK(T202/Y204) | 131.86 | 1 | LOXIMVI-signal1 | F8 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0033 | uM | 24 | hr | p-Histone H3(S10) | 288.89 | p-Rb(S807/S811) | 152.75 | p-S6(S235/S236 | 379.48 | 1 | Colo858-signal2 | F10 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0000 | uM | 24 | hr | p-Histone H3(S10) | 336.86 | p-Rb(S807/S811) | 161.69 | p-S6(S235/S236 | 384.38 | 1 | Colo858-signal2 | F11 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 2.0000 | uM | 24 | hr | p-Histone H3(S10) | 256.94 | p-Rb(S807/S811) | 69.35 | p-S6(S235/S236 | 26.20 | 1 | Colo858-signal2 | F3 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.8000 | uM | 24 | hr | p-Histone H3(S10) | 168.97 | p-Rb(S807/S811) | 57.67 | p-S6(S235/S236 | 47.25 | 1 | Colo858-signal2 | F4 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0512 | uM | 24 | hr | p-Histone H3(S10) | 219.70 | p-Rb(S807/S811) | 143.66 | p-S6(S235/S236 | 371.59 | 1 | Colo858-signal2 | F7 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0205 | uM | 24 | hr | p-Histone H3(S10) | 337.75 | p-Rb(S807/S811) | 156.22 | p-S6(S235/S236 | 357.37 | 1 | Colo858-signal2 | F8 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0033 | uM | 24 | hr | p-Histone H3(S10) | 300.67 | p-Rb(S807/S811) | 162.97 | p-S6(S235/S236 | 433.52 | 2 | Colo858-signal2 | G10 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0000 | uM | 24 | hr | p-Histone H3(S10) | 376.71 | p-Rb(S807/S811) | 165.48 | p-S6(S235/S236 | 397.13 | 2 | Colo858-signal2 | G11 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.3200 | uM | 24 | hr | p-Histone H3(S10) | 125.76 | p-Rb(S807/S811) | 58.82 | p-S6(S235/S236 | 110.32 | 2 | Colo858-signal2 | G5 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.1280 | uM | 24 | hr | p-Histone H3(S10) | 194.38 | p-Rb(S807/S811) | 84.75 | p-S6(S235/S236 | 196.38 | 2 | Colo858-signal2 | G6 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0205 | uM | 24 | hr | p-Histone H3(S10) | 327.85 | p-Rb(S807/S811) | 162.48 | p-S6(S235/S236 | 410.06 | 2 | Colo858-signal2 | G8 | |
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.8000 | uM | 24 | hr | p27 Kip1 | 482.18 | p-Rb(S807/S811) | 101.92 | p-ERK(T202/Y204) | 31.10 | 2 | LOXIMVI-signal1 | G4 | |
Vemurafenib | LOXIMVI | JNK-IN-8 | 2.0000 | uM | 24 | hr | p27 Kip1 | 533.87 | p-Rb(S807/S811) | 85.56 | p-ERK(T202/Y204) | 37.31 | 2 | LOXIMVI-signal1 | G3 |